1 amics are usually unobserved or difficult to
describe.
2 photoconductors and supercapacitors are also
described.
3 hio]-substituted 4-methylene-1-pyrrolines is
described.
4 nd far greater heterogeneity than previously
described.
5 8-dioxabicyclo[3.3.0]octan-3-one fragment is
described.
6 Myo1c-14-3-3beta interaction have yet to be
described.
7 Various pass/fail cut-off scores were
described.
8 osides in the presence of Fe(acac)(3)/CuI is
described.
9 lower tolerant subpopulation sizes have been
described.
10 f patients with reduced muscle endurance was
described.
11 f significant complications are incompletely
described.
12 e even under extreme elongations of 500% are
described.
13 ous, environmental, and genetic risk factors
described.
14 s specific subset of patients remains poorly
described.
15 g with modulation of surface composition, is
described.
16 et of a high-resolution mass spectrometer is
described.
17 l (incident NSAID use), and never users were
described.
18 obally, and contemporary trends are not well
described.
19 rocedure for collecting human mucus has been
described.
20 date, a binding site for P on L had not been
described.
21 been reported, but no large series has been
described.
22 We
describe 10 straightforward writing tips-and a web tool,
23 We
describe 156 cases over 5 years and evaluate the impact
24 We
describe 2 cases of renal lymphangiectasia in transplant
25 We
describe 2 large (>5 kb) recombination events, one of wh
26 We
describe 47 patients referred to our hospital between 21
27 We
describe a Bayesian hierarchical model, called Bayesian
28 of paromomycin and/or neomycin analogues, we
describe a cleavage of ring I from paromomycin that proc
29 Here, we
describe a computational method HiNT (Hi-C for copy Numb
30 We
describe a convenient assembly for screen printed carbon
31 Here we
describe a crow-sized stem bird, Falcatakely forsterae g
32 Here, we
describe a deficiency of cilia and flagella associated p
33 To address this problem, we
describe a diversity of approaches to quantify intrinsic
34 We therefore
describe a drug-able pathway whereby MDM2 ubiquitinates
35 Here, we
describe a function for NEK10 in the regulation of p53 t
36 We
describe a lethal combined nervous and reproductive syst
37 Here, we
describe a mechanism by which the innate immune system a
38 These observations
describe a mechanism for gating membrane fusion.
39 Using an in vitro reconstitution system, we
describe a mechanism for how mitochondrial inner-membran
40 Here we
describe a method for isolating human gut-associated lym
41 er potential (Psi) at predawn and midday and
describe a method that predicts Psi at stomatal closure
42 We
describe a method to correlate VAFRNA with gene expressi
43 Here, we
describe a methodology for targeted peptide quantificati
44 Here, we
describe a mouse model intended to reproduce hereditary
45 In this study, we
describe a new approach for preparing islets that enhanc
46 We
describe a new approach, which uses an existing underuti
47 Here, we
describe a new fossil specimen from Drimolen Main Quarry
48 Here, we
describe a new resource, stdpopsim, that attempts to rec
49 Here we
describe a new series of LPA(1) agonists among which der
50 Here, we
describe a novel framework to address this challenge.
51 In this study, we
describe a novel high throughput, micro-macro approach f
52 Herein, we
describe a novel, biomimetic, human bone platform for ad
53 Here we
describe a platform for efficient Cas12a gene editing in
54 Here we
describe a platform for the detection of IgG anti-drug a
55 We
describe a practical method for standardization of immun
56 Ha and colleagues
describe a previously unappreciated diversity of microbe
57 Here, we
describe a rare case of highly efficient near-cognate in
58 Here we
describe a robust genetic program that intrinsically att
59 Here we
describe a second class of local excitatory inputs to gr
60 We
describe a specific example of a gAP in humans linked to
61 We
describe a specimen support design that eliminates buckl
62 We
describe a strategy performed in Brazil to enable and ac
63 Here we
describe a strategy utilizing pan-family viral assays to
64 Here we
describe a subset of thymus recirculating IL18R(+) Tregs
65 studies used systems concepts to depict and
describe a system at one point in time.
66 We
describe a systematic complex genetic interaction analys
67 Here, we
describe a total synthesis of PvD(1), the defensin from
68 We
describe a universal sample multiplexing method for sing
69 We herein
described a convenient and quantitative assay to monitor
70 We
described a detailed SAR in TLR2 agonistic scaffolds and
71 Krusemark and colleagues recently
described a method to introduce DELs into living cells a
72 Here, we
described a new, comprehensive system of in silico metho
73 Previously, we
described a strategy to rapidly identify and generate ll
74 This Review
describes a density-based technique-magnetic levitation
75 The current study
describes a pooling strategy based on identification of
76 This article
describes a reduction in childhood vaccinations during t
77 eye per subject were analyzed and parameters
describing ACA width were measured at 500 and 750 mum fr
78 experimental and clinical nephropathies have
described accumulation of sphingolipids and sphingolipid
79 Alloy design principles are
described along with the structure and properties of EBM
80 acteristics of synthesized materials will be
described along with their ability to act as electrocata
81 In this study, we
describe an active poultry surveillance system establish
82 Herein, we
describe an adaptive signaling plasticity of CRLF2-rearr
83 Here we
describe an analysis method that provides data-driven es
84 per by Korshunov et al. in which the authors
describe an elegant strategy that Escherichia coli has e
85 Here we
describe an ex vivo cultured human skin explant model in
86 Herein, we
describe an expeditious total synthesis of hemiasterlin
87 Here, we
describe an integrative structure determination approach
88 Collectively, our results
describe an oncogenic mechanism of action for ACVR1 muta
89 Here, we
describe an optimization strategy for reducing scramblin
90 Here we
describe an ultrasensitive form of polymerization-based
91 We previously
described an exceptional period of viral control that oc
92 The CsTPSs
described and functionally characterized here include 13
93 zed DoMY-Seq by taking advantage of the well-
described and high-affinity interaction between KRAS and
94 fan anemia (DBA) was the first ribosomopathy
described and is a constitutional inherited bone marrow
95 Results: The instrument design is
described,
and its physical performance measurements are
96 use of two novel antigens and one previously
described antigen provided 96% sensitivity and 100% spec
97 w toxicity profiles of pyroglutamides herein
described are clues for the finding of a usable h-P2X7 a
98 f fossil Mesodescolea plicata was originally
described as a cycad, but new evidence from cuticle stru
99 show that murine IFE differentiation is best
described as a single step gradualistic process with a l
100 Cognitive effort is
described as aversive, and people will generally avoid i
101 Human speech perception can be
described as Bayesian perceptual inference but how are t
102 rates of change of ecological systems can be
described as fast, slow or abrupt.
103 ciation (SID); (3) avidin oligomers are best
described as heterogeneous ensembles with (essentially)
104 Evoked sensations were occasionally
described as naturalistic (e.g. touch or pressure), but
105 patient showed HLA-DQ8, which was previously
described as SHP-sensitive.
106 An increasing number of small studies
describing aspergillosis in COVID-19 patients with sever
107 Despite these
described associations, many cases of familial WT remain
108 d by a decline in homeostatic capacity, best
described at the molecular level.
109 Herein, we
describe bacterial metabolites with known or suspected n
110 ecific family Mysteriomorphidae was recently
described based on two fossil specimens from the Late Cr
111 everse INEPT FESTA (SRI-FESTA) experiment is
described,
based on the use of a modulated spin echo for
112 ntinual evolution to emerge, and whether the
described behavior is robust to variations in the given
113 An inverse relationship has been
described between procedural success and outcomes of all
114 their direct involvement in processing verbs
describing body part movements.
115 We used the model to
describe both the growth dynamics in our experiments of
116 ierarchical Bayesian models to these data to
describe both the mean trip number and duration.
117 oronavirus disease 2019 (COVID-19) have been
described,
but the understanding of their pathophysiolog
118 r several models of environmental volatility
described by continuous-time stochastic processes.
119 ction based on the pioneering circuit models
described by John Eccles, Masao Ito and Janos Szentagoth
120 PP-VHR was first
described by our group in 2006, and there have been no s
121 tities are known with a finite precision and
described by rational numbers.
122 primary visual cortex can be mathematically
described by the log-polar transform.
123 ugh such flow patterns can be, in principle,
described by the Navier-Stokes equations, extracting the
124 s sequences that fold onto novel RNA motifs (
described by tree graph topologies).
125 Body weight change was
described by using linear mixed models, including biomar
126 The approach
described can be used to test the magnitude of the contr
127 The objective of our study is to
describe changes in cardiac index, mean arterial pressur
128 y built and adjusted to experimental data to
describe changes in concentration in cowpea seed during
129 torical A. varius and A. zeteki populations,
describe changes in genetic diversity over time, assess
130 We aimed to
describe chronic health conditions and all-cause and cau
131 Here we
describe '
circularization for high-throughput analysis o
132 We
described clinical characteristics and adverse clinical
133 y diphtheria and diphtheria-like illness and
describe DAT use during 1996-2018 in the United States.
134 eous spatial sequences of metal ions that we
describe,
depending on the metal and synthesis temperatu
135 Constraining the fit to
describe diffusion over multiple length scales resulted
136 regarding the well-conducted studies clearly
describing discrepant effects of different methods of in
137 Here, we
describe diseases known to be influenced by iCP activity
138 Here, we
describe DNA enrichment of the zein gene from maize usin
139 2) m(-2) d(-1), was found to more accurately
describe DO consumption kinetics.
140 In this Perspective, we
describe efforts to decipher heterogeneity in T2D and de
141 This review
describes emerging innovations in offline and online MRI
142 X occupancy that accounts for all previously
described features of PAX inhibition, including state de
143 Nascent geographic atrophy (nGA)
describes features on OCT imaging previously observed to
144 and live-cell imaging of specific mRNAs, we
describe for the first time the subcellular localization
145 able; however, such parameters have not been
described for branched PLGA polymers.
146 their functions are similar to what we have
described for miRNAs, including acting on apoptosis, M.
147 henolic compounds and the main bioactivities
described for these secondary metabolites, to offer an o
148 est a transmission pathway analogous to that
described for Toxoplasma gondii, with infectious stages
149 We
describe here an original mode of generation of aneuploi
150 We
describe here an unconventional heterostructure composed
151 Putative regulators
described here add information to this hypothesis, expan
152 guidance for vaccine design, the antibodies
described here are promising candidates for COVID-19 tre
153 The findings
described here extend the number of vertebrate taxa wher
154 The method
described here is minimally invasive, and for the first
155 sm, which is conserved from fly to human, is
described here, with exosomes carrying unique cargos, in
156 For the optimized LC-MS/MS method
described herein, we applied the guidelines outlined in
157 Herein, we
describe how a biomimetic synthesis of bruceol, a pentac
158 currently annotated in the human genome and
describe how each class is assigned a standardised nomen
159 s and Pseudo-nitzschia multistriata Here, we
describe how functional genomics and reverse genetics ha
160 and functional magnetic resonance imaging to
describe how humans select predictors that might be most
161 As an example, they
describe how long interspersed nuclear repeat (LINE1) tr
162 (2019)
describe how the novel KRAS-G12C inhibitor AMG 510 can p
163 Here, we
describe how to use this method to label and/or genetica
164 high-resolution, pressure-based approach to
describe how two fishes, bluegill sunfish (Lepomis macro
165 Here we
describe how unexpanded CGG repeats and their translatio
166 Together, our model
describes how different mechanical properties of cells c
167 This article
describes how institutional generosity is critical in su
168 Our study provides a paradigm
describing how differential responses to regulatory inpu
169 The
described improvements in the imaging of bone metastases
170 photography, and the management of the cases
described in detail.
171 ing the transcription factor T-bet have been
described in normal and dysregulated immune responses.
172 metal or silicon electrodes, but the arrays
described in previous reports had low channel counts and
173 , and because microbiota characteristics are
described in relative terms.
174 nt recipients, the majority of complications
described in the literature, are early postoperative com
175 pment of other sensor components, as further
described in the review.
176 any discoveries are recent, and the findings
described in this Perspective are largely novel and yet
177 They have been
described in wines and the role of yeast in their format
178 This report
describes in detail the CAM consensus on iRORA.
179 We
describe invasive MRSA trends by strain type.
180 We focus on the cell cycle and
describe its dependence on pre-mRNA splicing and accurat
181 This study
describes key aspects of the interaction between primary
182 Herein, we
describe light-responsive tethers, containing an azobenz
183 can extract meaningful information, and also
describe limitations of pairwise contacts alone to predi
184 of MALDI-2 available in one instrument, the
described methodology could be a valuable tool in many a
185 quence motifs for transcription factors, and
describe motifs that correspond to other transcription f
186 t the molecular topology of the UAF complex,
describe new structural and functional domains that play
187 s study demonstrated that FLM can be used to
describe normal sleep-wake cycles of healthy adult dogs
188 alitative studies and two systematic reviews
describing older patients' experiences of care in acute
189 and theoretical analysis of AWC(ON), a well-
described olfactory neuron in C. elegans, here we derive
190 also provide a rationale for the previously
described "
olfactory lens," an increase in pheromone rec
191 We
describe our design, synthesis, and chemical study of a
192 This study sought to
describe outcomes after peripheral revascularization and
193 t trial is the first phase 3 safety study to
describe outcomes in children treated with dabigatran et
194 riptional profiles in human glioblastoma and
describe patient-derived xenografts with species-conserv
195 Two modes of indole signalling have been
described:
persistent and pulse.
196 This review
describes platforms benefiting from these cytosensors to
197 We also
describe potent inhibition of SARS-CoV-2 strain 2019-nCo
198 study uses electronic health record data to
describe primary care services offered by US community h
199 r shootin1a) isoform, which both contain the
described PRR and WH2 domains.
200 Comparative data are limited and
describe re-treatment rates rather than retinal structur
201 Here, I
describe recent progress in understanding the evolution,
202 ung recruitment was assessed by the recently
described recruitment to inflation ratio.
203 international consensus is reached, studies
describing remission should clearly define all 3 compone
204 In addition, we
describe research pipelines that broaden evidence-based
205 This article
describes resources for clinicians to use when circumsta
206 We
described respiratory diphtheria cases reported to the N
207 inct conformation not observed in previously
described RSV G-antibody structures.
208 However, recent studies
describing slowly increasing dopamine signals have inste
209 potent and selective LPA(1) receptor agonist
described so far (E(max) = 118%, EC(50) = 0.24 muM, K(D)
210 However, the glycan's structure has not been
described so far.
211 Multiple soil properties
described sorption of PFASs better than any single prope
212 With ~36,000
described species, Agaricomycetes are among the most suc
213 great ambitions of structural biology is to
describe structure-function relationships quantitatively
214 ck of rapid diagnostic tests which can fully
describe TB resistance patterns is a major challenge in
215 This study uses national survey data to
describe testosterone levels by age in youths aged 6 to
216 is a known mitotic regulator, and it is well-
described that KIF11 is necessary for the formation and
217 We have previously
described that tailoring the rate-response programming o
218 In particular, we
describe the application of this mechanism to a dual nic
219 We also
describe the BioImage Archive, a deposition database for
220 itself and in complex with ARL6(GTP), and we
describe the changes in BBSome conformation induced by A
221 The purpose of this study was to
describe the characteristics and analyze the prognostic
222 ransfer (IHT) patients after pancreatectomy,
describe the characteristics of transferring hospitals,
223 In this retrospective cohort study, we
describe the clinical presentation and workup of parathy
224 It is also challenging to fully
describe the critical cellular events that drive oncogen
225 Here, we
describe the crystal structures of two distinct isoforms
226 For each domain, we
describe the current status of target establishment (i.e
227 Herein, we
describe the design and performance of an integrated mic
228 Here, we
describe the development and use of an assay to monitor
229 Here we
describe the development of a pan-RAS biologic inhibitor
230 Here, we
describe the development of dual-color (DC) tsMSQ to ana
231 Herein, we
describe the discovery and optimization of a class of po
232 We
describe the emergence of a protein domain that confers
233 To
describe the epidemiological and clinical characteristic
234 To
describe the epidemiology of hospitalizations for acute
235 In this Review we
describe the epidemiology, clinical features, course, an
236 to define the quality of end products and to
describe the evolution of processes that involve blendin
237 We also
describe the expression of a functional vitamin D recept
238 Here, we
describe the extent of resistance of E. dermatitidis to
239 Existing approaches
describe the fusion of cell aggregates by analogy with t
240 The overall goal of this study was to
describe the genomic landscape of myeloma using deep who
241 In this article, we
describe the immune environments associated with major B
242 We
describe the impact that COVID-19 has had on geographica
243 Here we
describe the in vivo dynamics of hunger-promoting AgRP n
244 The aim of this review is to
describe the interaction of clinical documentation with
245 We
describe the isolation of a yeast top2 mutant (top2-F102
246 interactions are essential to quantitatively
describe the magnetism of CrI(3) but quantum rescaling c
247 Herein, we
describe the mechanisms and consequences of TLR-mediated
248 In this review, we
describe the molecular structure of TRPV6 and discuss ho
249 Our aim was to
describe the natural history of XLA.
250 ichard Semon introduced the term "engram" to
describe the neural substrate for storing memories.
251 inhibitory effects on myeloid cells, we also
describe the nonclassic roles attributed to this pleiotr
252 The primary objective was to
describe the OCT features at the margin of the coloboma.
253 We
describe the partial cranium and skeleton of a new dipro
254 ion by methyl-beta-cyclodextrin as a tool to
describe the physiological role of cholesterol in glutam
255 Our study aimed to
describe the prevalence of albuminuria amongst people wh
256 Here we
describe the production of a range of mini-spidroins wit
257 lex networks considering overloaded edges to
describe the redundant capacity for edges and capture th
258 We
describe the roles of Bhlhe40 in the circulating and tis
259 Herein, we
describe the synthesis and evaluation of immunotherapeut
260 First, we
describe the temporal relationship between appetite neur
261 is Evaluation investigation was conducted to
describe the trajectory of mortality and health-related
262 Here, we
describe the two-phase process by which antigen drives t
263 Here, we
describe the UBPs developed by three research teams and
264 on microscopy and in vivo ophthalmoscopy, we
describe the ultrastructural changes in the eye between
265 Here we
describe the use of discarded wound dressings as a novel
266 In this report, we
describe the utility of one of these enzymes, Nepenthesi
267 Herein, we
describe the utilization of a photocatalyst to oxidize a
268 We
describe the well-known interactions with RNA polymerase
269 This study
described the clinical profile and associated outcomes a
270 In addition, we
described the differences in their synaptic influence.
271 We previously
described the H3.3K27M mutation as a shared neoantigen i
272 We
described the overall uptake of telemonitoring and uptak
273 We previously
described the regulatory events that control the timely
274 This work
describes the concept, design, and realization of the fi
275 This review
describes the current understanding of LapA-mediated bio
276 The parameter [Formula: see text]
describes the degree to which particle size lowers the m
277 This study
describes the determination of lead at trace levels by s
278 This report
describes the first application of the novel NMR-based m
279 This report
describes the first detailed kinetic analysis of the Ban
280 This paper
describes the first implementation of an array of two-di
281 r coupled fluid-flow and geomechanical model
describes the physical processes inducing seismicity cor
282 bon): POC (particulate organic carbon) ratio
describes the relative amount of inorganic carbon in the
283 This essay
describes the role of community pharmacists in implement
284 a local tetragonal framework more accurately
describes the structure than the originally proposed cub
285 This study
describes the use of a subtype-specific Kv7 activator to
286 This study
describes the use of amino acid quantitation and amino-a
287 This study
describes the use of tailored poly(acrylic acid)-based (
288 emiological studies are of great interest in
describing the dynamics of epidemics, they struggle to f
289 ent knowledge of IP(3)Rs, we develop a model
describing the effect of functional interaction (cross t
290 ingle radiologist dictated a standard phrase
describing the lesion into a microphone, simulating clin
291 A mathematical model
describing the viral infection dynamics reveals two tran
292 are used to measure aggregate structure and
describe their morphology probability distribution and s
293 The purpose of this study was to
describe trends in maternal pre-pregnancy hypertension a
294 cut Public Utilities Regulatory Authority to
describe trends in medical exemptions from utility disco
295 es for nonadiabatic dynamics simulations and
describe tricks and problems when using them in machine
296 e synthesis of sulfonyl 9-fluorenylidenes is
described,
which consists of a one-pot straightforward t
297 ard synthesis of substituted phthalimides is
described,
which includes base-mediated Michael addition
298 Combined, they
describe with only three parameters the induction-force-
299 nary tract infection) for delirium have been
described,
with most patients having both types.
300 A broad phenotypic spectrum has been
described,
with potentially severe extracutaneous manife